Documents & Downloads

TRK-IN-26

TRK Inhibitor

TRK-IN-26 is a selective TRK inhibitor designed for cancer research applications. It targets tropomyosin receptor kinases (TRKs), which play a crucial role in the development and progression of various tumors. This compound demonstrates significant inhibitory activity against TRK signaling, making it an essential tool for investigating TRK-related biological pathways and therapeutic strategies in oncology.

Out of Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Specifications

Manufacturer	Adooq Bioscience
Actions	Inhibitor
CAS Number	2412309-52-3
Applications	TRK Inhibitor
Formula	C₃₀H₂₂F₂N₆O₄
Molecular Weight	568.53
SMILES	O=C(C1=CC=C(N(C2=CC=C(C=C2)F)C1=O)OC)NC3=CC=C(C(F)=C3)OC4=CC5=C(C=C4C6=CNN=C6)N(C)N=C5

Storage & Solubility

In Vitro Solubility

Reported Solubility

No reported solubility data are available for this product.

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.